purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmaceutical Blockchain
1.2 Key Market Segments
1.2.1 Pharmaceutical Blockchain Segment by Type
1.2.2 Pharmaceutical Blockchain Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmaceutical Blockchain Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmaceutical Blockchain Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmaceutical Blockchain Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmaceutical Blockchain Market Competitive Landscape
3.1 Global Pharmaceutical Blockchain Sales by Manufacturers (2019-2024)
3.2 Global Pharmaceutical Blockchain Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmaceutical Blockchain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical Blockchain Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmaceutical Blockchain Sales Sites, Area Served, Product Type
3.6 Pharmaceutical Blockchain Market Competitive Situation and Trends
3.6.1 Pharmaceutical Blockchain Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmaceutical Blockchain Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmaceutical Blockchain Industry Chain Analysis
4.1 Pharmaceutical Blockchain Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmaceutical Blockchain Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmaceutical Blockchain Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical Blockchain Sales Market Share by Type (2019-2024)
6.3 Global Pharmaceutical Blockchain Market Size Market Share by Type (2019-2024)
6.4 Global Pharmaceutical Blockchain Price by Type (2019-2024)
7 Pharmaceutical Blockchain Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical Blockchain Market Sales by Application (2019-2024)
7.3 Global Pharmaceutical Blockchain Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmaceutical Blockchain Sales Growth Rate by Application (2019-2024)
8 Pharmaceutical Blockchain Market Segmentation by Region
8.1 Global Pharmaceutical Blockchain Sales by Region
8.1.1 Global Pharmaceutical Blockchain Sales by Region
8.1.2 Global Pharmaceutical Blockchain Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmaceutical Blockchain Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmaceutical Blockchain Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmaceutical Blockchain Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmaceutical Blockchain Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmaceutical Blockchain Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Chronicled Inc.
9.1.1 Chronicled Inc. Pharmaceutical Blockchain Basic Information
9.1.2 Chronicled Inc. Pharmaceutical Blockchain Product Overview
9.1.3 Chronicled Inc. Pharmaceutical Blockchain Product Market Performance
9.1.4 Chronicled Inc. Business Overview
9.1.5 Chronicled Inc. Pharmaceutical Blockchain SWOT Analysis
9.1.6 Chronicled Inc. Recent Developments
9.2 Doc.AI
9.2.1 Doc.AI Pharmaceutical Blockchain Basic Information
9.2.2 Doc.AI Pharmaceutical Blockchain Product Overview
9.2.3 Doc.AI Pharmaceutical Blockchain Product Market Performance
9.2.4 Doc.AI Business Overview
9.2.5 Doc.AI Pharmaceutical Blockchain SWOT Analysis
9.2.6 Doc.AI Recent Developments
9.3 Embleema
9.3.1 Embleema Pharmaceutical Blockchain Basic Information
9.3.2 Embleema Pharmaceutical Blockchain Product Overview
9.3.3 Embleema Pharmaceutical Blockchain Product Market Performance
9.3.4 Embleema Pharmaceutical Blockchain SWOT Analysis
9.3.5 Embleema Business Overview
9.3.6 Embleema Recent Developments
9.4 Factom Inc.
9.4.1 Factom Inc. Pharmaceutical Blockchain Basic Information
9.4.2 Factom Inc. Pharmaceutical Blockchain Product Overview
9.4.3 Factom Inc. Pharmaceutical Blockchain Product Market Performance
9.4.4 Factom Inc. Business Overview
9.4.5 Factom Inc. Recent Developments
9.5 FarmaTrust
9.5.1 FarmaTrust Pharmaceutical Blockchain Basic Information
9.5.2 FarmaTrust Pharmaceutical Blockchain Product Overview
9.5.3 FarmaTrust Pharmaceutical Blockchain Product Market Performance
9.5.4 FarmaTrust Business Overview
9.5.5 FarmaTrust Recent Developments
9.6 Guardtime Federal
9.6.1 Guardtime Federal Pharmaceutical Blockchain Basic Information
9.6.2 Guardtime Federal Pharmaceutical Blockchain Product Overview
9.6.3 Guardtime Federal Pharmaceutical Blockchain Product Market Performance
9.6.4 Guardtime Federal Business Overview
9.6.5 Guardtime Federal Recent Developments
9.7 Hashed Health
9.7.1 Hashed Health Pharmaceutical Blockchain Basic Information
9.7.2 Hashed Health Pharmaceutical Blockchain Product Overview
9.7.3 Hashed Health Pharmaceutical Blockchain Product Market Performance
9.7.4 Hashed Health Business Overview
9.7.5 Hashed Health Recent Developments
9.8 IBM Corporation
9.8.1 IBM Corporation Pharmaceutical Blockchain Basic Information
9.8.2 IBM Corporation Pharmaceutical Blockchain Product Overview
9.8.3 IBM Corporation Pharmaceutical Blockchain Product Market Performance
9.8.4 IBM Corporation Business Overview
9.8.5 IBM Corporation Recent Developments
9.9 Medicalchain
9.9.1 Medicalchain Pharmaceutical Blockchain Basic Information
9.9.2 Medicalchain Pharmaceutical Blockchain Product Overview
9.9.3 Medicalchain Pharmaceutical Blockchain Product Market Performance
9.9.4 Medicalchain Business Overview
9.9.5 Medicalchain Recent Developments
9.10 Microsoft Corporation
9.10.1 Microsoft Corporation Pharmaceutical Blockchain Basic Information
9.10.2 Microsoft Corporation Pharmaceutical Blockchain Product Overview
9.10.3 Microsoft Corporation Pharmaceutical Blockchain Product Market Performance
9.10.4 Microsoft Corporation Business Overview
9.10.5 Microsoft Corporation Recent Developments
9.11 Organizations Mentioned
9.11.1 Organizations Mentioned Pharmaceutical Blockchain Basic Information
9.11.2 Organizations Mentioned Pharmaceutical Blockchain Product Overview
9.11.3 Organizations Mentioned Pharmaceutical Blockchain Product Market Performance
9.11.4 Organizations Mentioned Business Overview
9.11.5 Organizations Mentioned Recent Developments
9.12 American Society of Clinical Oncology (ASCO)
9.12.1 American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Basic Information
9.12.2 American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Product Overview
9.12.3 American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Product Market Performance
9.12.4 American Society of Clinical Oncology (ASCO) Business Overview
9.12.5 American Society of Clinical Oncology (ASCO) Recent Developments
9.13 Association of Clinical Trials Organizations (ACTO)
9.13.1 Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Basic Information
9.13.2 Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Product Overview
9.13.3 Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Product Market Performance
9.13.4 Association of Clinical Trials Organizations (ACTO) Business Overview
9.13.5 Association of Clinical Trials Organizations (ACTO) Recent Developments
9.14 Castor EDC
9.14.1 Castor EDC Pharmaceutical Blockchain Basic Information
9.14.2 Castor EDC Pharmaceutical Blockchain Product Overview
9.14.3 Castor EDC Pharmaceutical Blockchain Product Market Performance
9.14.4 Castor EDC Business Overview
9.14.5 Castor EDC Recent Developments
9.15 Clinical Supplies Management Holdings, Inc.
9.15.1 Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Basic Information
9.15.2 Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Product Overview
9.15.3 Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Product Market Performance
9.15.4 Clinical Supplies Management Holdings, Inc. Business Overview
9.15.5 Clinical Supplies Management Holdings, Inc. Recent Developments
9.16 ClinicalTrials.gov
9.16.1 ClinicalTrials.gov Pharmaceutical Blockchain Basic Information
9.16.2 ClinicalTrials.gov Pharmaceutical Blockchain Product Overview
9.16.3 ClinicalTrials.gov Pharmaceutical Blockchain Product Market Performance
9.16.4 ClinicalTrials.gov Business Overview
9.16.5 ClinicalTrials.gov Recent Developments
9.17 Medpace
9.17.1 Medpace Pharmaceutical Blockchain Basic Information
9.17.2 Medpace Pharmaceutical Blockchain Product Overview
9.17.3 Medpace Pharmaceutical Blockchain Product Market Performance
9.17.4 Medpace Business Overview
9.17.5 Medpace Recent Developments
9.18 N-SIDE
9.18.1 N-SIDE Pharmaceutical Blockchain Basic Information
9.18.2 N-SIDE Pharmaceutical Blockchain Product Overview
9.18.3 N-SIDE Pharmaceutical Blockchain Product Market Performance
9.18.4 N-SIDE Business Overview
9.18.5 N-SIDE Recent Developments
9.19 Quanticate
9.19.1 Quanticate Pharmaceutical Blockchain Basic Information
9.19.2 Quanticate Pharmaceutical Blockchain Product Overview
9.19.3 Quanticate Pharmaceutical Blockchain Product Market Performance
9.19.4 Quanticate Business Overview
9.19.5 Quanticate Recent Developments
9.20 Society for Clinical Trials
9.20.1 Society for Clinical Trials Pharmaceutical Blockchain Basic Information
9.20.2 Society for Clinical Trials Pharmaceutical Blockchain Product Overview
9.20.3 Society for Clinical Trials Pharmaceutical Blockchain Product Market Performance
9.20.4 Society for Clinical Trials Business Overview
9.20.5 Society for Clinical Trials Recent Developments
10 Pharmaceutical Blockchain Market Forecast by Region
10.1 Global Pharmaceutical Blockchain Market Size Forecast
10.2 Global Pharmaceutical Blockchain Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmaceutical Blockchain Market Size Forecast by Country
10.2.3 Asia Pacific Pharmaceutical Blockchain Market Size Forecast by Region
10.2.4 South America Pharmaceutical Blockchain Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical Blockchain by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pharmaceutical Blockchain Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmaceutical Blockchain by Type (2025-2030)
11.1.2 Global Pharmaceutical Blockchain Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmaceutical Blockchain by Type (2025-2030)
11.2 Global Pharmaceutical Blockchain Market Forecast by Application (2025-2030)
11.2.1 Global Pharmaceutical Blockchain Sales (K Units) Forecast by Application
11.2.2 Global Pharmaceutical Blockchain Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings